Evolent Health Inc Stock Price, News & Analysis

Evolent Health (NYSE: EVH) will have its CEO Frank Williams, President Seth Blackley, and CFO John Johnson participate in the Baird 2020 Global Healthcare Conference on September 10, 2020, at 9:05 a.m. ET. A live webcast can be accessed through the investor relations section of Evolent's website. Evolent Health specializes in clinical and administrative solutions aimed at improving healthcare quality and affordability, serving a broad base of payers and providers. The company is recognized for its population health program accreditation.

Evolent Health (NYSE: EVH) announced that CEO Frank Williams, President Seth Blackley, and CFO John Johnson will present at two upcoming investor conferences. The presentations will take place at the Wells Fargo 2020 Virtual Healthcare Conference on September 9, 2020, at 10:40 a.m. ET and at the Baird 2020 Global Healthcare Conference on September 10, 2020, at 9:05 a.m. ET. Evolent Health specializes in health care solutions that improve health affordability and management, serving a national base of leading payers and providers.

Evolent Health (NYSE: EVH) announced a significant financial maneuver involving the issuance of $117 million principal amount of 3.50% Convertible Senior Notes due 2024. This issuance includes $84.2 million in exchange for existing 2.00% Convertible Senior Notes due 2021, alongside $32.8 million generated through cash subscriptions. Expected net proceeds are estimated at $27.4 million. Following this transaction, $26.7 million of the 2021 Notes will remain outstanding. The new notes will be convertible into cash or Evolent's Class A common stock at an initial price of approximately $18.23 per share, representing a 30% premium over the stock's closing price on August 13, 2020.

Evolent Health (EVH) reported a 24.3% increase in GAAP revenue, reaching $238.6 million for Q2 2020 compared to Q2 2019. Despite this growth, the company recorded a net loss of $(203.5) million, impacted by a non-cash goodwill impairment of $215.1 million. Adjusted EBITDA stood at $9.0 million, showcasing operational improvements. Evolent also added two new partners and anticipates over 30% revenue growth in its Services business for the year, alongside a focus on margin enhancement. There will be a change in leadership with Seth Blackley being promoted to CEO on October 1, 2020.

Evolent Health, a healthcare company listed on NYSE as EVH, announced its participation in the 40th Annual Canaccord Genuity Growth Conference. CEO Frank Williams, President Seth Blackley, and CFO John Johnson will present on August 13, 2020, at 10:30 a.m. ET. A live webcast will be available on Evolent's investor relations website. Evolent Health is known for its clinical and administrative solutions that enhance healthcare affordability and quality, holding the first NCQA Population Health Program Accreditation.

Evolent Health (NYSE: EVH) reported significant findings in the July issue of The American Journal of Managed Care, indicating that remote health advising and care management interventions can markedly decrease hospitalizations and medical spending for high-risk Medicare beneficiaries. The study revealed that participating patients had a 21% reduction in inpatient admissions and a 22% decrease in total medical costs. Those deeply engaged in the program experienced even greater benefits, with 47% fewer readmissions and a 42% reduction in medical spending. The analysis followed nearly 1,900 high-risk participants over six months.

Evolent Health, Inc. (NYSE: EVH) will release its second quarter 2020 operating results on August 4, 2020, after market close. A conference call to discuss these results will occur at 5:00 p.m. Eastern Time on the same day. Interested parties can listen by dialing 855.940.9467 or 412.317.6034 for international calls, referencing the "Evolent Health call." An audio playback will be available on Evolent's investor relations website for one week post-call.

Evolent delivers clinical and administrative solutions aimed at improving health care affordability and simplicity.

Evolent Health (NYSE: EVH) announced a definitive agreement for Molina Healthcare to acquire certain assets of Passport Health Plan. The deal includes Passport's brand, operational infrastructure, and specific agreements, with Molina paying $20M upfront and up to $40M based on member retention in 2021. The implied total valuation for Passport, including statutory capital, is estimated between $150M and $190M. Evolent will continue to provide services to Passport through the end of 2020 and is set to offer specialty care management services in Kentucky starting in 2021.